Yingcai Niu

1.5k total citations
38 papers, 1.2k citations indexed

About

Yingcai Niu is a scholar working on Molecular Biology, Plant Science and Hepatology. According to data from OpenAlex, Yingcai Niu has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Plant Science and 9 papers in Hepatology. Recurrent topics in Yingcai Niu's work include Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Alzheimer's disease research and treatments (7 papers). Yingcai Niu is often cited by papers focused on Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Alzheimer's disease research and treatments (7 papers). Yingcai Niu collaborates with scholars based in China and United States. Yingcai Niu's co-authors include Miaoxian Dong, Jicheng Liu, Zhou Li, Chengchong Li, Guihua Xing, Xiaoming Li, Chunlei Yu, Xuemei Zhao, Xiaoli Wang and Yu Zou and has published in prestigious journals such as Free Radical Biology and Medicine, Carbohydrate Polymers and Biochemical Pharmacology.

In The Last Decade

Yingcai Niu

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingcai Niu China 21 407 303 237 214 198 38 1.2k
Yue Zhu China 24 506 1.2× 246 0.8× 188 0.8× 96 0.4× 171 0.9× 75 1.6k
Aiman S. El‐Khatib Egypt 22 323 0.8× 513 1.7× 129 0.5× 184 0.9× 178 0.9× 50 1.6k
Miaoxian Dong China 23 568 1.4× 342 1.1× 328 1.4× 165 0.8× 327 1.7× 35 1.4k
Su Jin Jeon South Korea 18 468 1.1× 346 1.1× 152 0.6× 164 0.8× 309 1.6× 33 1.1k
Bin Lü China 28 757 1.9× 263 0.9× 94 0.4× 213 1.0× 305 1.5× 66 1.8k
Hui‐Kang Liu Taiwan 20 514 1.3× 205 0.7× 192 0.8× 162 0.8× 124 0.6× 64 1.2k
Ping‐Hsiao Shih Taiwan 22 803 2.0× 188 0.6× 232 1.0× 347 1.6× 198 1.0× 30 2.0k
Wanglin Jiang China 28 927 2.3× 331 1.1× 126 0.5× 300 1.4× 165 0.8× 72 2.0k
Ru Zhou China 26 592 1.5× 207 0.7× 192 0.8× 168 0.8× 123 0.6× 57 1.4k
Lvyi Chen China 25 767 1.9× 268 0.9× 249 1.1× 152 0.7× 198 1.0× 47 1.6k

Countries citing papers authored by Yingcai Niu

Since Specialization
Citations

This map shows the geographic impact of Yingcai Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingcai Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingcai Niu more than expected).

Fields of papers citing papers by Yingcai Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingcai Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingcai Niu. The network helps show where Yingcai Niu may publish in the future.

Co-authorship network of co-authors of Yingcai Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingcai Niu. A scholar is included among the top collaborators of Yingcai Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingcai Niu. Yingcai Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niu, Chengu, Miaoxian Dong, & Yingcai Niu. (2024). Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease. European Journal of Medicinal Chemistry. 269. 116359–116359. 10 indexed citations
2.
Niu, Chengu, Miaoxian Dong, & Yingcai Niu. (2024). Role of Glutathione in Parkinson's Disease Pathophysiology and Therapeutic Potential of Polyphenols. Phytotherapy Research. 38(12). 5567–5582. 4 indexed citations
3.
Niu, Chengu, Yu Zou, Miaoxian Dong, & Yingcai Niu. (2024). Plant-derived compounds as potential neuroprotective agents in Parkinson's disease. Nutrition. 130. 112610–112610. 1 indexed citations
4.
Niu, Yingcai, Jing Zhang, & Miaoxian Dong. (2021). Nrf2 as a potential target for Parkinson’s disease therapy. Journal of Molecular Medicine. 99(7). 917–931. 42 indexed citations
5.
Yu, Chunlei, et al.. (2021). Ferulic acid exerts Nrf2-dependent protection against prenatal lead exposure-induced cognitive impairment in offspring mice. The Journal of Nutritional Biochemistry. 91. 108603–108603. 22 indexed citations
6.
Yu, Chunlei, Jing Zhang, Xiaoming Li, Jicheng Liu, & Yingcai Niu. (2020). Astragaloside IV-induced Nrf2 nuclear translocation ameliorates lead-related cognitive impairments in mice. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(1). 118853–118853. 13 indexed citations
7.
Zhao, Xuemei, et al.. (2020). Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats. Digestive Diseases and Sciences. 65(10). 2925–2936. 25 indexed citations
8.
Zou, Yu, et al.. (2019). Astragaloside IV and ferulic acid synergistically promote neurite outgrowth through Nrf2 activation. Mechanisms of Ageing and Development. 180. 70–81. 12 indexed citations
9.
Hua, Rong, et al.. (2018). Rosmarinic acid attenuates β-amyloid-induced oxidative stress via Akt/GSK-3β/Fyn-mediated Nrf2 activation in PC12 cells. Free Radical Biology and Medicine. 120. 114–123. 75 indexed citations
10.
Dong, Haiying, et al.. (2017). Astragaloside IV synergizes with ferulic acid to suppress hepatic stellate cells activation in vitro. Free Radical Research. 51(2). 167–178. 13 indexed citations
11.
12.
Yu, Chunlei, Xuemei Zhao, & Yingcai Niu. (2015). Ferulic Acid Protects Against Lead Acetate-Induced Inhibition of Neurite Outgrowth by Upregulating HO-1 in PC12 Cells: Involvement of ERK1/2-Nrf2 Pathway. Molecular Neurobiology. 53(9). 6489–6500. 34 indexed citations
13.
14.
Dong, Haiying, Zhiying Gao, Chengchong Li, et al.. (2014). Analyzing 395,793 samples shows significant association between rs999737 polymorphism and breast cancer. Tumor Biology. 35(6). 6083–6087. 2 indexed citations
15.
Dong, Haiying, Yuzhang Liu, Yu Zou, et al.. (2013). Alteration of the ERK5 pathway by hydroxysafflor yellow A blocks expression of MEF2C in activated hepatic stellate cellsin vitro: Potential treatment for hepatic fibrogenesis. Pharmaceutical Biology. 52(4). 435–443. 9 indexed citations
16.
Li, Chengchong, Xiaoming Li, Xuemei Zhao, et al.. (2012). Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro. European Journal of Pharmaceutical Sciences. 46(5). 397–404. 27 indexed citations
17.
Wang, Gang, Jicheng Liu, Miaoxian Dong, et al.. (2011). Beta-asarone attenuates beta-amyloid-induced apoptosis through the inhibition of the activation of apoptosis signal-regulating kinase 1 in SH-SY5Y cells.. PubMed. 66(1). 44–51. 31 indexed citations
18.
Li, Chengchong, Guihua Xing, Miaoxian Dong, et al.. (2010). Beta-asarone protection against beta-amyloid-induced neurotoxicity in PC12 cells via JNK signaling and modulation of Bcl-2 family proteins. European Journal of Pharmacology. 635(1-3). 96–102. 63 indexed citations
19.
Li, Jiaming, Gang Wang, Jicheng Liu, et al.. (2010). Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo. European Journal of Pharmacology. 649(1-3). 195–201. 74 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yue Zhu Breakdown of academic impact, for papers by Aiman S. El‐Khatib Breakdown of academic impact, for papers by Miaoxian Dong Breakdown of academic impact, for papers by Su Jin Jeon Breakdown of academic impact, for papers by Bin Lü Breakdown of academic impact, for papers by Hui‐Kang Liu Breakdown of academic impact, for papers by Ping‐Hsiao Shih Breakdown of academic impact, for papers by Wanglin Jiang Breakdown of academic impact, for papers by Ru Zhou Breakdown of academic impact, for papers by Lvyi Chen
Rankless by CCL
2026